4.6 Article

Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept

Related references

Note: Only part of the references are listed.
Review Anatomy & Morphology

Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies

Pei-Yu Chu et al.

Summary: The chick CAM model has been a valuable alternative in oncology research, showing increased xenograft take rates and retention of tumor heterogeneity. Various imaging techniques and data analysis have been widely applied to study tumor metastasis, angiogenesis, and therapeutic response to novel agents.

CELLS TISSUES ORGANS (2022)

Article Oncology

Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients

Monika Pizon et al.

Summary: This study presents a novel process for harvesting patient-derived xenografts (PDX) from circulating cancer stem cells, providing a fast, low-cost, easy-to-use, and efficient preclinical platform for drug screening, therapy optimization, and biomarker discovery. The established PDX model on the chorioallantoic membrane has been shown to closely resemble the primary tumor and can reflect the aggressiveness and proliferation capacity of the primary tumor.

CANCERS (2022)

Review Oncology

In vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity

Gianluigi De Renzi et al.

Summary: This review highlights the main attempts to establish in vitro CTC cultures from patients with different types of tumors and emphasizes the importance and potential applications of this practice. In vitro cultures offer an opportunity to increase the number of tumor cells isolated from different stages of the disease, allowing for a deeper understanding of the nature of neoplastic diseases, optimizing treatment strategies, and potentially preventing the development of treatment resistance.

CANCER DRUG RESISTANCE (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

The Chicken Chorioallantoic Membrane Tumor Assay as a Relevant In Vivo Model to Study the Impact of Hypoxia on Tumor Progression and Metastasis

Kelly Harper et al.

Summary: Hypoxia in the tumor microenvironment is a negative prognostic factor associated with tumor progression and metastasis, making it an attractive therapeutic target for anti-tumor therapy. The use of the CAM model effectively supports the development of hypoxic zones in a variety of tumor types, offering a valuable platform for studying hypoxia and testing drugs targeting this tumor microenvironment.

CANCERS (2021)

Article Oncology

High-Throughput Nucleotide Resolution Predictions of Assay Limitations Increase the Reliability and Concordance of Clinical Tests

Jonathan Bieler et al.

Summary: The study introduces a method for computing reliability metrics for each genomic position and sample interrogated by an NGS assay, which accurately predicts the lowest reliably detectable variant fraction and improves reliability in screening lung cancer samples.

JCO CLINICAL CANCER INFORMATICS (2021)

Article Oncology

Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications

Nuria Carmona-Ule et al.

Summary: In this study, circulating tumor cells (CTCs) were cultured in vitro using growth factors and Nanoemulsions. The cultured CTCs showed mesenchymal and stem cell characteristics, and their culture duration was predictive of progression-free survival in breast cancer patients. The subset of CTCs capable of ex vivo growth may represent the population with metastatic potential in vivo.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Circulating tumor cells: biology and clinical significance

Danfeng Lin et al.

Summary: CTCs, tumor cells that have sloughed off the primary tumor and circulate in the blood, have potential for identifying targets against cancer metastasis. Detecting these rare CTCs in the massive pool of blood cells is challenging, but emerging detection technologies have deepened our understanding of their biology and clinical applications. Molecular markers, such as epithelial cell adhesion molecule, play a key role in CTC detection, with properties like epithelial-to-mesenchymal transition and stemness indicating increased metastatic capacity.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Oncology

Technologies for circulating tumor cell separation from whole blood

Petra Banko et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Oncology

Liquid biopsy: one cell at a time

Su Bin Lim et al.

NPJ PRECISION ONCOLOGY (2019)

Article Biochemistry & Molecular Biology

CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients

S. Lefort et al.

ONCOGENE (2017)

Article Multidisciplinary Sciences

Highly sensitive and specific Alu-based quantification of human cells among rodent cells

Kodai Funakoshi et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

TRIzol and Alu qPCR-based quantification of metastatic seeding within the skeleton

J. Preston Campbell et al.

SCIENTIFIC REPORTS (2015)

Article Multidisciplinary Sciences

The isolation and characterization of CTC subsets related to breast cancer dormancy

Monika Vishnoi et al.

SCIENTIFIC REPORTS (2015)

Article Multidisciplinary Sciences

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells

Estrelania S. Williams et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)

Article Biochemistry & Molecular Biology

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

Cassandra L. Hodgkinson et al.

NATURE MEDICINE (2014)

Article Multidisciplinary Sciences

Lectin-Like Oxidized LDL Receptor-1 Is an Enhancer of Tumor Angiogenesis in Human Prostate Cancer Cells

Ivan Gonzalez-Chavarria et al.

PLOS ONE (2014)

Article Anatomy & Morphology

The Neural Crest and Cancer: A Developmental Spin on Melanoma

Paul M. Kulesa et al.

CELLS TISSUES ORGANS (2013)

Review Biotechnology & Applied Microbiology

The role of tumour-stromal interactions in modifying drug response: challenges and opportunities

Douglas W. McMillin et al.

NATURE REVIEWS DRUG DISCOVERY (2013)

Article Cell Biology

The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis

Lixin Zhang et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Oncology

Recent Advances and Prospects in the Isolation by Size of Epithelial Tumor Cells (ISET) Methodology

Yu-Chao Ma et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2013)

Article Medical Laboratory Technology

Circulating Epithelial Cells in Patients with Benign Colon Diseases

Klaus Pantel et al.

CLINICAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Quantitative Analysis of Cancer Metastasis using an Avian Embryo Model

Trenis D. Palmer et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)